The first to file in the US gets a 180-day period of exclusivity during which it can be the sole marketer of the generic version
Many states require BMI of 30 or higher with comorbidities, or BMI of 35 or higher regardless of comorbidities
A cohort study conducted in Denmark with 309,166 individuals diagnosed with diabetes revealed that treatment with GLP-1RAs led to a 50% decrease in amputations related to diabetes, when compared to those who did not receive GLP-1RA treatment [78]
The Phase 3 SYNCHRONIZE trials incorporate slower dose titration with the option to pause dosing during more severe symptoms, which should improve tolerability
Nausea, vomiting, and diarrhea are common during dose escalation
It helps with weight loss and blood sugar management by: Increasing insulin production in your pancreas to keep your blood sugar levels in the normal range Suppressing your appetite, reducing cravings and keeping you feeling full for longer (when combined with GLP-1) Optimising the way your body stores fat and uses fat and glucose for energy Glucagon Glucagon is a peptide hormone produced by the pancreas that prevents blood sugar from getting too low